ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      68,061.42
      0.50%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Omega Therapeutics Inc (OMGA)

      7. Omega Therapeutics Inc (OMGA) News

      OMGA

      Omega Therapeutics (OMGA)

      Omega Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:OMGA
      DateTimeSourceHeadlineSymbolCompany
      05/31/20244:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMGAOmega Therapeutics Inc
      05/30/20245:10PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:OMGAOmega Therapeutics Inc
      05/30/20247:00AMGlobeNewswire Inc.Omega Therapeutics To Participate In Two Upcoming Investor ConferencesNASDAQ:OMGAOmega Therapeutics Inc
      05/29/20247:00AMGlobeNewswire Inc.Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business OfficerNASDAQ:OMGAOmega Therapeutics Inc
      05/08/20247:00AMGlobeNewswire Inc.Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic ControllersNASDAQ:OMGAOmega Therapeutics Inc
      05/06/20247:06AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OMGAOmega Therapeutics Inc
      05/06/20247:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMGAOmega Therapeutics Inc
      05/06/20247:00AMGlobeNewswire Inc.Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:OMGAOmega Therapeutics Inc
      04/23/20247:00AMGlobeNewswire Inc.Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual MeetingNASDAQ:OMGAOmega Therapeutics Inc
      04/09/20247:00AMGlobeNewswire Inc.Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic ControlNASDAQ:OMGAOmega Therapeutics Inc
      03/28/20249:15AMGlobeNewswire Inc.Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic UpdateNASDAQ:OMGAOmega Therapeutics Inc
      03/06/20247:00AMGlobeNewswire Inc.Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024NASDAQ:OMGAOmega Therapeutics Inc
      02/09/20245:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMGAOmega Therapeutics Inc
      02/09/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMGAOmega Therapeutics Inc
      02/09/20244:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMGAOmega Therapeutics Inc
      01/05/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMGAOmega Therapeutics Inc
      01/02/20244:05PMGlobeNewswire Inc.Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:OMGAOmega Therapeutics Inc
      12/11/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMGAOmega Therapeutics Inc
      12/04/20234:00PMGlobeNewswire Inc.Omega Therapeutics to Participate in the H.C. Wainwright 4th Annual Precision Oncology Virtual ConferenceNASDAQ:OMGAOmega Therapeutics Inc
      11/27/20237:01PMPR Newswire (US)Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science LeadersNASDAQ:OMGAOmega Therapeutics Inc
      11/21/20236:00AMPR Newswire (US)Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of GeneticsNASDAQ:OMGAOmega Therapeutics Inc
      11/20/20234:00PMGlobeNewswire Inc.Omega Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:OMGAOmega Therapeutics Inc
      11/13/20237:00AMGlobeNewswire Inc.Omega Therapeutics Showcases Bidirectional and Multiplexed Epigenomic Control of Gene Expression in Preclinical Models of Liver Inflammation and FibrosisNASDAQ:OMGAOmega Therapeutics Inc
      11/09/20237:03AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OMGAOmega Therapeutics Inc
      11/09/20237:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMGAOmega Therapeutics Inc
      11/09/20237:00AMGlobeNewswire Inc.Omega Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:OMGAOmega Therapeutics Inc
      11/07/20234:00PMGlobeNewswire Inc.Omega Therapeutics to Participate in The Jefferies London Healthcare ConferenceNASDAQ:OMGAOmega Therapeutics Inc
      10/31/20237:00AMGlobeNewswire Inc.Omega Therapeutics Presents New Preclinical Data Demonstrating Pre-Transcriptional Modulation of Multiple CXCL Genes by a Single Epigenomic ControllerNASDAQ:OMGAOmega Therapeutics Inc
      10/16/20237:00AMGlobeNewswire Inc.Omega Therapeutics Presents New Preclinical Data Supporting the Potential of OTX-2101 in Combination Settings for Treatment of NSCLCNASDAQ:OMGAOmega Therapeutics Inc
      10/11/20234:00PMGlobeNewswire Inc.Omega Therapeutics Announces Two Poster Presentations on Liver Inflammation and Fibrosis at AASLD’s The Liver Meeting® 2023NASDAQ:OMGAOmega Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:OMGA